Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CAPLIPOINT | NSE
-5.40
-0.31%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
21/04/2026
1,748.80
1,759.90
1,768.00
1,740.00
Caplin Point Laboratories Limited develops produces markets and exports generic pharmaceutical formulations and branded products in India. The company provides liquid and lyophilized injections ophthalmic droppers prefilled bags tablets dry syrups soft gels capsules suppositories liquid syrups in bottles liquid injectables in ampoules and vials prefilled syringes emulsion injection in ampoules and vials topicals and sachets. It also operates QueTenX an e-commerce website. The company was incorporated in 1990 and is headquartered in Chennai India.
View LessLow 6-Month Volatility (<30%)
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Operating Margin (> 25%)
Strong Revenue Growth (> 10%)
Smallcap (300M - 2B USD)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
26.9%1 month
34.5%3 months
28.5%6 months
26.4%30.77
-
6.32
0.00
0.00
22.40
8.27
-
5.75B
132.93B
1.42B
0.26
29.60
19.90
16.10
21.69
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
254.30
Range1M
299.50
Range3M
438.70
Rel. volume
0.48
Price X volume
86.24M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Jubilant Pharmova Limited | JUBLPHARMA | Drug Manufacturers-Specialty & Generic | 906.95 | 141.58B | 0.16% | 33.46 | 67.43% |
| Concord Biotech Limited | CONCORDBIO | Biotechnology | 1043.7 | 110.21B | -2.13% | 67.34 | 0.64% |
| JUBILANT INGREVIA LTD | JUBLINGREA | Biotechnology | 658.75 | 102.81B | -1.29% | 67.54 | 27.04% |
| Strides Pharma Science Limited | STAR | Drug Manufacturers-Specialty & Generic | 996.95 | 92.49B | 0.05% | n/a | 118.41% |
| PGHL | PGHL | Drug Manufacturers-Specialty & Generic | 5084.3 | 83.85B | -0.03% | 42.84 | 1.78% |
| Blue Jet Healthcare Limited | BLUEJET | Biotechnology | 415.3 | 72.04B | 0.72% | 57.09 | 0.19% |
| Aarti Pharmalabs Limited | AARTIPHARM | Drug Manufacturers-Specialty & Generic | 706.7 | 64.05B | 4.52% | 24.57 | 16.23% |
| FDC Limited | FDC | Drug Manufacturers-Specialty & Generic | 363.8 | 60.03B | 1.07% | 28.02 | 0.98% |
| Supriya Lifescience Limited | SUPRIYA | Biotechnology | 620.75 | 49.78B | 0.15% | 32.96 | 0.67% |
| Sun Pharma Advanced Research Company Limited | SPARC | Drug Manufacturers-Specialty & Generic | 144.05 | 46.75B | -0.31% | n/a | 48.63% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Vedant Fashions Limited | MANYAVAR | Apparel Retail | 450.85 | 110.28B | 0.48% | 84.26 | 27.74% |
| Vertoz Advertising Limited | VERTOZ | Advertising Agencies | 50.53 | 44.32B | -5.04% | 48.67 | 10.74% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 271.87 | 15.94B | 0.54% | 30.54 | 80.30% |
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 100.64 | 14.83B | -0.92% | 28.83 | 43.67% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 197.59 | 7.05B | 3.12% | 120.49 | 191.28% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 214.72 | 6.94B | -0.03% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 61 | 1.68B | -1.98% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 93.13 | 1.35B | 1.38% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 74.4 | 829.47M | -0.24% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 24 | 416.64M | 0.50% | 58.62 | 43.14% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 22.40 | 24.85 | Par |
| Ent. to Revenue | 8.27 | 11.40 | Cheaper |
| PE Ratio | 30.77 | 51.36 | Cheaper |
| Price to Book | 6.32 | 6.83 | Par |
| Dividend Yield | 0.26 | 0.52 | Poor |
| Std. Deviation (3M) | 28.47 | 42.17 | Lower Risk |
| Debt to Equity | 0.00 | 0.35 | Cheaper |
| Debt to Assets | 0.00 | 0.17 | Cheaper |
| Market Cap | 132.93B | 290.82B | Emerging |